France does not engage in industrial production of active pharmaceutical ingredients (APIs) — the figure stands at 0 tonnes in 2026. Despite being home to giants like Sanofi, French pharmaceutical companies have historically focused on drug development and final formulation rather than the synthesis of raw substances. API production has largely moved to China and India, where production costs and environmental regulations are lower. France, meanwhile, maintains its leadership in research and clinical trials. In the global ranking of 197 countries, the country holds 33-th place.
France world ranking
Country position on the scale from last to first place for this indicator.
Change over time
Change in indicator over the available period.
Values — tonnes
Top countries by Pharmaceutical active pharmaceutical ingredients (APIs) production
Where France stands in the world ranking.
People also search for
Other pages of the reference by this indicator.